Human colonic microbiota associated with diet, obesity and weight loss

By S. Duncan, G. Lobley, G. Holtrop, J. Ince, Alexandra M. Johnstone, P. Louis, H. Flint. International Journal of Obesity, 2008

1,243 citations recorded by the source corpus.

Subfields: Gastroenterology, Infectious Diseases, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/ac4d99e8f8894617fc53b5acd1f0b9ec993fa2cb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Gastroenterology

In Infectious Diseases

In Molecular Biology

Citations in the corpus

Intestinal microbiota in patients with nonalcoholic fatty liver disease (2013, neutral): “ALT (U/L)** 17 (6-41) b 32 (14-54) 69 (22-168)”
Specificity of polysaccharide use in intestinal Bacteroides species determines diet-induced microbiota alterations (2010, positive): “In addition, changes in composition have been associated with obesity and weight loss; however, factors that cause these changes are not well defined (Duncan et al., 2008; Ley et al., 2006).”
The core gut microbiome, energy balance and obesity (2009, methodology): “However, a FISH-based study of obese adults on 2 month-long diets and a FISH/qPCR-based study of pregnant overweight and lean women failed to show consistent phylum-level differences in community structure (Collado et al. 2008; Duncan et al. 2008).”
Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation (2015, background): “, 2006), Eubacterium/Roseburia (Duncan et al., 2008), and Eubacterium rectale (Cotillard et al.”
Impact of antibiotics on the human microbiome and consequences for host health (2022, result): “Some studies suggest that an increased ratio of Firmicutes to Bacteroidetes rather than specific levels is as- sociated with obesity (Kasai et al., 2015), though results are con- flicting (Duncan et al., 2008; Schwiertz et al., 2010).”
The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients? (2020, neutral): “9 • ND ND During the course of the study ND ND ND Metabolic syndrome Gastrointestinal problems FISH ND = ND [29]”
Metagenomic biomarker discovery and explanation (2011, background): “Changes in microbial abundances in the gut, oral cavity, and skin have been associated with disease states ranging from obesity [15-17] to psoriasis [18].”
Impact of the gut microbiota on inflammation, obesity, and metabolic disease (2016, positive): “However, other human studies in which gut bacterial composition was compared between lean individuals and individuals with obesity have failed to confirm the association between obesity and a decreased Bacteroidetes:Firmicutes ratio [49, 50].”
Meta-analyses of human gut microbes associated with obesity and IBD (2014, background): “Many studies show an increased ratio of Firmicutes:Bacteroidetes [8,13–19] although some other studies show no trend, or even the opposite trend [20–24].”
Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss (2010, result): “However, modification of the Firmicutes-to-Bacteroidetes ratio observed in obese individuals was not confirmed in other studies (12).”